Big Gain For Alterity Therapeutics Limited
Wed, Mar 11, 2020 at 05:30 PM
Alterity Therapeutics Limited (ATHE:NASDAQ) jumped higher at $0.9, representing a gain of 50%. From Tue 25 Feb 20, the stock recorded 30.00% Up Days and 27.27% Green Days
The share price of the company has been moving sideways in recent weeks.
About Alterity Therapeutics Limited (ATHE:NASDAQ)
Prana Biotechnology Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.
Top 10 Gainers:
- Ladenburg Thalmann Financial Services Inc (LTSK:NYSEMKT), 142.86%
- BIO-key International, Inc. (BKYI:NASDAQ), 140.82%
- Tiziana Life Sciences PLC (TLSA:NASDAQ), 92.68%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 91.29%
- Ladenburg Thalmann Financial Services Inc (LTSH:NYSEMKT), 53.85%
- Alterity Therapeutics Limited (ATHE:NASDAQ), 50%
- Inovio Pharmaceuticals, Inc. (INO:NASDAQ), 46.84%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 44.79%
- Planet Green Holdings Corp. (PLAG:NYSEMKT), 42.07%
- Mallinckrodt plc (MNK:NYSE), 39.27%